Trial Profile
A double blind randomised study comparing the pharmacodynamic effects of Arimidex[anastrozole] with tamoxifen as neoadjuvant treatment of primary postmenopausal breast cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 01 Aug 2005
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Tamoxifen
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms IMPACT
- 01 Aug 2005 New trial record.